Arora Ashish, the Chief Executive Officer of $CRCT, sold 21,250 shares of the company on 10-07-2025 for an estimated $119,227. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 2,739,061 shares of this class of $CRCT stock.
$CRCT Insider Trading Activity
$CRCT insiders have traded $CRCT stock on the open market 37 times in the past 6 months. Of those trades, 0 have been purchases and 37 have been sales.
Here’s a breakdown of recent trading of $CRCT stock by insiders over the last 6 months:
- ARORA ASHISH (Chief Executive Officer) has made 0 purchases and 33 sales selling 1,275,989 shares for an estimated $7,833,873.
- MATT TUTTLE (General Counsel & Secretary) sold 40,491 shares for an estimated $230,219
- RYAN HARMER (Principal Accounting Officer) has made 0 purchases and 3 sales selling 35,170 shares for an estimated $201,273.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRCT Hedge Fund Activity
We have seen 85 institutional investors add shares of $CRCT stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 402,897 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,727,612
- CWA ASSET MANAGEMENT GROUP, LLC added 329,200 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,228,684
- CITADEL ADVISORS LLC added 310,053 shares (+107.7%) to their portfolio in Q2 2025, for an estimated $2,099,058
- D. E. SHAW & CO., INC. removed 291,895 shares (-78.0%) from their portfolio in Q2 2025, for an estimated $1,976,129
- DIMENSIONAL FUND ADVISORS LP added 274,846 shares (+94.2%) to their portfolio in Q2 2025, for an estimated $1,860,707
- JACOBS LEVY EQUITY MANAGEMENT, INC added 203,434 shares (+65.7%) to their portfolio in Q2 2025, for an estimated $1,377,248
- VANGUARD GROUP INC removed 174,335 shares (-3.7%) from their portfolio in Q2 2025, for an estimated $1,180,247
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRCT Analyst Ratings
Wall Street analysts have issued reports on $CRCT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Sell" rating on 04/14/2025
To track analyst ratings and price targets for $CRCT, check out Quiver Quantitative's $CRCT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
